Published in Steroids on January 25, 2010
Podocytopathy in diabetes: a metabolic and endocrine disorder. Am J Kidney Dis (2011) 1.10
Tubulointerstitial disease in diabetic nephropathy. Int J Nephrol Renovasc Dis (2014) 0.82
Inhibition of estradiol synthesis attenuates renal injury in male streptozotocin-induced diabetic rats. Am J Physiol Renal Physiol (2011) 0.81
Sugar, sex, and TGF-β in diabetic nephropathy. Semin Nephrol (2012) 0.80
Testicular Metabolic Reprogramming in Neonatal Streptozotocin-Induced Type 2 Diabetic Rats Impairs Glycolytic Flux and Promotes Glycogen Synthesis. J Diabetes Res (2015) 0.79
Diabetes alters aromatase enzyme levels in gonadal tissues of rats. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.77
Male Sexual Dysfunction and Chronic Kidney Disease. Front Med (Lausanne) (2017) 0.75
Effects of intraperitoneal insulin versus subcutaneous insulin administration on sex hormone-binding globulin concentrations in patients with type 1 diabetes mellitus. Endocr Connect (2016) 0.75
Combined inhibition of aromatase activity and dihydrotestosterone supplementation attenuates renal injury in male streptozotocin (STZ)-induced diabetic rats. Am J Physiol Renal Physiol (2012) 0.75
A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab (1999) 10.64
Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab (2006) 3.46
Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care (2004) 3.07
The early natural history of nephropathy in type 1 diabetes: I. Study design and baseline characteristics of the study participants. Diabetes (2002) 3.00
Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int (1992) 2.51
Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus. Ann Intern Med (1992) 2.43
Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev (2002) 2.42
Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care (2005) 2.26
Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care (2000) 2.18
Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metab (2008) 1.90
Low IGF-I and elevated testosterone during puberty in subjects with type 1 diabetes developing microalbuminuria in comparison to normoalbuminuric control subjects: the Oxford Regional Prospective Study. Diabetes Care (2003) 1.68
The impact of gender on the progression of chronic renal disease. Am J Kidney Dis (1995) 1.62
Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group. Diabetes Care (1999) 1.44
Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab (2004) 1.43
Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men. J Clin Endocrinol Metab (1993) 1.33
Androgen deficiency, diabetes, and the metabolic syndrome in men. Curr Opin Endocrinol Diabetes Obes (2007) 1.26
Contrasting testosterone concentrations in type 1 and type 2 diabetes. Diabetes Care (2006) 1.18
Gender and the progression of renal disease. J Am Soc Nephrol (2002) 1.13
Mild Hypogonadotropic hypogonadism in obese men. Metabolism (1982) 1.11
Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study. Eur J Endocrinol (2008) 1.10
Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men. Metabolism (1994) 1.05
Pathophysiology of sex hormone binding globulin (SHBG): relation to insulin. J Steroid Biochem Mol Biol (1991) 1.03
The roles of oestrogen in the male. Trends Endocrinol Metab (1998) 1.02
Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo. J Clin Endocrinol Metab (1995) 1.01
Age at onset of childhood-onset type 1 diabetes and the development of end-stage renal disease: a nationwide population-based study. Diabetes Care (2006) 0.98
Low serum testosterone concentration in middle-aged men with type 2 diabetes. Endocr J (2007) 0.93
Clinical factors associated with urinary albumin excretion in type II diabetes. Am J Kidney Dis (1995) 0.91
Progression of diabetic nephropathy in normotensive type 1 diabetic patients. Kidney Int Suppl (1999) 0.91
Sex hormone-binding globulin and testosterone in individuals with childhood diabetes. Diabetes Care (2008) 0.89
Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with proteinuria, coronary heart disease, and glycemic control in type 1 diabetic patients. Diabetes Care (2004) 0.86
Steroids in adult men with type 1 diabetes: a tendency to hypogonadism. Diabetes Care (2003) 0.86
Arterial hypertension and microalbuminuria in IDDM: the Italian Microalbuminuria Study. Diabetologia (1994) 0.84
Increased testosterone in type I diabetic subjects with severe retinopathy. Ophthalmology (1990) 0.81
Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA (2005) 3.01
The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes (2009) 2.80
Serum adiponectin concentration is a positive predictor of all-cause and cardiovascular mortality in type 1 diabetes. J Intern Med (2011) 2.30
Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care (2005) 2.26
Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care (2011) 2.20
The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care (2011) 2.16
Sex-related differences in the long-term risk of microvascular complications by age at onset of type 1 diabetes. Diabetologia (2011) 2.07
Leisure-time physical activity and development and progression of diabetic nephropathy in type 1 diabetes: the FinnDiane Study. Diabetologia (2015) 2.05
Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes. Diabetologia (2011) 1.90
Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol (2011) 1.82
New susceptibility loci associated with kidney disease in type 1 diabetes. PLoS Genet (2012) 1.79
Cyclodextrin protects podocytes in diabetic kidney disease. Diabetes (2013) 1.71
Impaired vascular dilatation in women with a history of pre-eclampsia. J Hypertens (2006) 1.62
A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes. Diabetes (2009) 1.55
1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol Syst Biol (2008) 1.51
Birth weight is inversely correlated to adult systolic blood pressure and pulse pressure in type 1 diabetes. Hypertension (2004) 1.51
Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J Am Soc Nephrol (2013) 1.49
Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes--indication of an increased environmental pressure? Diabetologia (2003) 1.41
Variation in SLC19A3 and Protection From Microvascular Damage in Type 1 Diabetes. Diabetes (2015) 1.40
Many patients with Type 1 diabetes estimate their prandial insulin need inappropriately. J Diabetes (2010) 1.39
Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy. Diabetes (2012) 1.36
High-throughput pedigree drawing. Eur J Hum Genet (2005) 1.36
Serum adiponectin is increased in type 1 diabetic patients with nephropathy. Diabetes Care (2005) 1.35
Nephrinuria in diabetic nephropathy of type 1 diabetes. Diabetes (2003) 1.29
Serum concentration of cystatin C and risk of end-stage renal disease in diabetes. Diabetes Care (2012) 1.26
Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study. BMJ (2011) 1.26
Mechanisms of disease: Pathway-selective insulin resistance and microvascular complications of diabetes. Nat Clin Pract Endocrinol Metab (2005) 1.26
Heritability of proliferative diabetic retinopathy. Diabetes (2008) 1.25
The MIF receptor CD74 in diabetic podocyte injury. J Am Soc Nephrol (2008) 1.22
Candidate gene association study for diabetic retinopathy in persons with type 2 diabetes: the Candidate gene Association Resource (CARe). Invest Ophthalmol Vis Sci (2011) 1.22
Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes. Diabetes (2008) 1.20
Serum lipopolysaccharide activity is associated with the progression of kidney disease in finnish patients with type 1 diabetes. Diabetes Care (2009) 1.18
Development of new peripheral arterial occlusive disease in patients with type 2 diabetes during a mean follow-up of 11 years. Diabetes Care (2003) 1.17
Incidence of type 1 diabetes in Finland. JAMA (2013) 1.15
Altered age-related blood pressure pattern in type 1 diabetes. Circulation (2004) 1.15
Advanced glycation end products are direct modulators of β-cell function. Diabetes (2011) 1.14
Health-related quality of life in patients with type 1 diabetes--association with diabetic complications (the FinnDiane Study). Nephrol Dial Transplant (2009) 1.10
Evidence for a role of hot flushes in vascular function in recently postmenopausal women. Obstet Gynecol (2009) 1.09
Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes. Diabetologia (2010) 1.08
A functional polymorphism in the manganese superoxide dismutase gene and diabetic nephropathy. Diabetes (2007) 1.08
Relationship between lipid profiles and kidney function in patients with type 1 diabetes. Diabetologia (2007) 1.07
Association between angiotensin-converting enzyme gene polymorphisms and diabetic nephropathy: case-control, haplotype, and family-based study in three European populations. J Am Soc Nephrol (2007) 1.07
Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care (2009) 1.06
Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy. Diabetologia (2004) 1.05
Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum. MAGMA (2006) 1.04
Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes. Diabetes Care (2008) 1.04